O'Leary

MyVoice:CF is acceptable, appropriate, and usable for those with cystic fibrosis (CF). Among a sample of 43 participants, preliminary effectiveness evaluation suggests that MyVoice:CF improves self-efficacy in and frequency of reproductive health communication.
 

Dr. Kazmerski , Olivia Stransky, Catherine Wright, Dr. Birru Talabi, Dr. Callegari, Dr. Chang, Dr. Miller, Ashley Deal, Raelynn O'Leary, and Dr. Borrero conducted a study on our femtech tool MyVoice:CF showing that the tool increases self-efficacy and reproductive health communication for those with cystic fibrosis.  

Read more about their findings here: https://pubmed.ncbi.nlm.nih.gov/37833123/